Search results
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2,...
FOX 23 News Albany· 1 day agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage...
El Paso and Teller counties to see $66 million in grants to address opioid epidemic
Colorado Springs Gazette· 1 day agoEl Paso and Teller counties are expected to receive $66 million through 2038 to address the opioid...
Delta-8 clarification unlikely as stalemate persists
The Purdue Exponent· 6 days agoIn the nearly six years since a federal law appeared to open the doors to delta-8, the marijuana-like drug has grown into a billion-dollar Hoosier industry. “The legislature ...
Report: Prosecution of DEA drug cases down
WJTV Jackson· 5 days agoAlthough fentanyl drug use is rising across the United States, a new report found a decrease in drug case prosecutions referred by the Drug Enforcement...
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks...
Benzinga· 3 days agoPresident Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule...
Travis County shifting focus to prevent fentanyl OD deaths
San Antonio Express-News· 5 days agoWhen Travis County Judge Andy Brown got a phone call two weeks ago about a rash of overdoses that...
Psychemedics (NASDAQ:PMD) Announces Quarterly Earnings Results
ETF DAILY NEWS· 5 days agoPsychemedics (NASDAQ:PMD – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.12) earnings per share (EPS) for the quarter, reports. Psychemedics had a ...
Illness took away her voice. AI created a replica she carries in her phone
Wisconsin State Journal· 3 days agoArtificial intelligence voice-cloning technology carries many risks. But a team of doctors and their...
Mira Pharmaceuticals Advances Preclinical Trials T | Newswise
Newswise· 2 days agoMIAMI, May 20, 2024 -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric ...
